GSK573719/GW642444
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for GSK573719/GW642444, covering 2014-02-10 to 2014-04-11. Get the full timeline:
Most recent: Clinical Trial Update: An Exercise Endurance Study to Evaluate the Effects of Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients With a Dual Bronchodilator: GSK573719/GW642444.Study B [Phase 3]